We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+58.39%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$2.77B
AUM Growth
+$909M
Cap. Flow
+$51.4M
Cap. Flow %
1.86%
Top 10 Hldgs %
31.68%
Holding
209
New
25
Increased
86
Reduced
78
Closed
18

Top Buys

Rank Stock Value
1
MGNI icon
Magnite
MGNI
+$28.4M
2
BL icon
BlackLine
BL
+$24.3M
3
HQY icon
HealthEquity
HQY
+$21.8M
4
WK icon
Workiva
WK
+$18M
5
AXON
Axon Enterprise
AXON
+$16.7M

Top Sells

Rank Stock Value
1
CHGG icon
Chegg
CHGG
+$46.7M
2
PAYC icon
Paycom
PAYC
+$27.2M
3
ENPH icon
Enphase Energy
ENPH
+$17.8M
4
SPSC icon
SPS Commerce
SPSC
+$16.7M
5
PCTY icon
Paylocity
PCTY
+$15.1M

Sector Composition

Rank Sector Weight
1 Technology 35.16%
2 Healthcare 18.29%
3 Industrials 13.17%
4 Consumer Discretionary 9.72%
5 Communication Services 6.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RDWR icon
126
Radware
RDWR
$1.2B
$3.34M 0.12%
141,495
+3,240
+2% +$74.4K
CRSP icon
127
CRISPR Therapeutics
CRSP
$5.17B
$3.21M 0.12%
43,625
+9,498
+28% +$555K
CYBR
128
DELISTED
CyberArk
CYBR
$3.17M 0.11%
31,887
+7,264
+30% +$707K
TWLO icon
129
Twilio
TWLO
$38B
$3.08M 0.11%
14,026
-39,168
-74% -$6.29M
OKTA icon
130
Okta
OKTA
$26.2B
$3.02M 0.11%
15,092
-10,160
-40% -$1.72M
CTMX icon
131
CytomX Therapeutics
CTMX
$750M
$2.98M 0.11%
358,122
+92,449
+35% +$859K
TER icon
132
Teradyne
TER
$57.1B
$2.97M 0.11%
35,177
+140
+0.4% +$9.38K
NEWR
133
DELISTED
New Relic, Inc.
NEWR
$2.94M 0.11%
42,740
+2,107
+5% +$126K
MPWR icon
134
Monolithic Power Systems
MPWR
$67.9B
$2.87M 0.1%
12,126
-183
-1% -$37K
PRLB icon
135
Protolabs
PRLB
$2.14B
$2.86M 0.1%
25,430
+95
+0.4% +$9.75K
PTC icon
136
PTC
PTC
$16.4B
$2.83M 0.1%
36,400
-9,148
-20% -$648K
JRVR icon
137
James River Group Holdings
JRVR
$210M
$2.83M 0.1%
+62,808
New +$2.33M
XNCR icon
138
Xencor
XNCR
$1.6B
$2.78M 0.1%
85,869
+321
+0.4% +$9.84K
BEAM icon
139
Beam Therapeutics
BEAM
$2.82B
$2.71M 0.1%
96,598
-1,678
-2% -$36.2K
NPTN
140
DELISTED
NEOPHOTONICS CORP
NPTN
$2.67M 0.1%
300,338
+66,414
+28% +$573K
TW icon
141
Tradeweb Markets
TW
$21.9B
$2.65M 0.1%
45,586
-38,060
-46% -$2.19M
KRRO icon
142
Korro Bio
KRRO
$199M
$2.53M 0.09%
2,179
-45
-2% -$40.7K
VICR icon
143
Vicor
VICR
$9.63B
$2.51M 0.09%
34,924
-7,245
-17% -$407K
AERI
144
DELISTED
Aerie Pharmaceuticals
AERI
$2.44M 0.09%
165,494
+47,216
+40% +$698K
ICPT
145
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$2.41M 0.09%
50,342
+231
+0.5% +$17.8K
SLAB icon
146
Silicon Laboratories
SLAB
$7.2B
$2.36M 0.09%
23,497
+3,303
+16% +$309K
PFPT
147
DELISTED
Proofpoint, Inc.
PFPT
$2.35M 0.09%
21,164
+1,181
+6% +$135K
CTG
148
DELISTED
Computer Task Group, Inc.
CTG
$2.28M 0.08%
566,293
-61,453
-10% -$251K
QTS
149
DELISTED
QTS REALTY TRUST, INC.
QTS
$2.27M 0.08%
35,441
-33,897
-49% -$2.13M
SPRO icon
150
Spero Therapeutics
SPRO
$71.2M
$2.25M 0.08%
166,606
-4,828
-3% -$54.2K
4 5
6
7 8

Similar funds

BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return

Granahan Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, Granahan Investment Management held 209 positions worth $2.77B, up 49% from $1.86B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Granahan Investment Management's Q2 2020 filing shows 25 new, 86 increased, 78 reduced and 18 closed positions. Its largest new stake was BlackLine: 364,676 shares worth $30.2M. The largest sale was Chegg, an estimated $46.7M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Healthcare and Industrials.

  • Granahan Investment Management's largest Q2 2020 buy was BlackLine: 364,676 shares worth $30.2M.
  • Granahan Investment Management added most to Magnite in Q2 2020, an estimated $28.4M increase.
  • Granahan Investment Management's biggest Q2 2020 reduction was Chegg, cutting an estimated $46.7M.
  • Granahan Investment Management fully exited The Ensign Group in Q2 2020, selling an estimated $14M.
  • Granahan Investment Management's ten largest holdings make up 32% of its $2.77B portfolio in Q2 2020.
  • Granahan Investment Management opened 25 new positions and closed 18 in Q2 2020.
  • Granahan Investment Management's portfolio value rose 49% quarter-over-quarter to $2.77B.

Based on Granahan Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.